By Andrew Ramage
Environmental Monitoring: Implications of GMP Annex 1 for large pharma
The draft revision of the EU GMP Annex 1 has been received with mixed feelings. The European Medicines Agency (EMA) is currently working its away through the 6000+ comments that have come about since the release of this revision.
Read More
Growth Promotion Testing: A Guide to Good Practices
Get an in-depth understanding of key considerations and best practices when undertaking growth promotion testing (GPT).
